|
THE SAFE INJECTION GLOBAL NETWORK (SIGN) IS
ORGANIZING ITS ANNUAL MEETING IN CAIRO (EGYPT)
The Egyptian capital, Cairo, will be hosting the
annual meeting of the Safe Injection Global Network (SIGN), which has
its secretariat at the headquarters of the World Health Organization
(WHO) in Geneva, on 23 and 24 October 2000. About 100 participants and
experts are expected to attend. The Egyptian Minister of Health will
open the work of the meeting, which will last two days. Experts from
all over the world and all interested in this question can follow this
meeting on line and live at the SIGN Internet site: www.injectionsafety.org
The Network (SIGN) is a
coalition of several public and private partners, including WHO,
UNICEF, UNAIDS, nongovernmental organizations (NGOs), governments,
universities, health workers and the world of industry. It was formed
in Geneva in October 1999 with a view to uniting the strengths and
skills of several partners to work together on the issue of injection
safety.
(WHO) is preparing new technical guidelines on
preventing infection from injections. These guidelines will be
discussed in advance of the Cairo meeting. Soon after the Cairo
meeting, it will be possible to consult them in the form of a
provisional document open for comments from the public on the SIGN
Internet site.
At the Cairo meeting, the participants will review
the results of the actions and activities undertaken since last year,
exchange information, compare experiences and coordinate their
advocacy and public awareness activities.
"In the last year, some progress has been made
in the field of injection safety. Egypt, which is demonstrating its
desire for progress by hosting the meeting, has recently set up a
national coalition called "Developing Infection Control in
Egypt" (DICE). This new coalition is very active in its work to
ensure injection safety in the country. Some interesting initiatives
are also taking place in other countries. Pakistan has set up a
national "SIGN" group, Tanzania has launched an education
campaign for the population and health workers, and Burkina Faso has
made spectacular progress with injection safety between 1995 and 2000.
I believe this represents a real growth of awareness, but there is
still a lot to be done," said Dr Yvan Hutin, of the Department of
Blood Safety and Clinical Technology at WHO and head of the SIGN
secretariat. "The Cairo meeting will help us to better coordinate
our actions in light of what has already been achieved," he
added.
The members of the Global Network (SIGN) are
collaborating in three strategic fields:
- Creating and maintaining a common strategic framework;
- Promoting exchange of ideas and information to encourage
research on innovative solutions and cost-effectiveness;
- Coordinating advocacy, communication and awareness strategies.
WHO recommends a threefold strategy for injection
safety:
- Promoting change in the behaviour of health workers and the
general public in order to reduce abusive recourse to injections;
- Ensuring sufficient supplies of products such as syringes and
needles in order to avoid reuse of the same materials;
- Appropriate arrangements to dispose of used cutting materials
and sharps.
WHO, UNICEF, the United Nations Population Fund (UNFPA)
and the International Federation of Red Cross and Red Crescent
Societies (IFRC) have recommended in a joint declaration that
autodestruct and single-use disposable syringes should be used for
vaccination by 2003. The price of these syringes has come down
considerably and there is now little difference in price as compared
with ordinary disposable syringes.
Injections are one of the most common acts of
preventive and curative medicine. Every year, 12 billion injections
are given throughout the world, 90% of them for therapeutic purposes
and the rest for prevention (essentially for vaccination). In many
countries, deeply rooted beliefs about the supposedly superior
efficiency of injections are current among the public as well as
health workers.
Many injections given for therapeutic purposes are
useless and may pose risks if all the rules of hygiene and safety are
not respected. Every year, risky injections cause 8 to 16 million
cases of infection with the hepatitis B virus, 2.3 to 4.7 million
cases of infection with the hepatitis C virus and 75 000 to
150 000 cases of infection with HIV/AIDS.
For further information on injection safety, the
SIGN web site may be consulted at www.injectionsafety.org and the
Department of Blood Safety and Clinical Technology may be contacted at
WHO, Avenue Appia 20, CH-1211 Geneva 27, Switzerland. Tel: (+41 22)
791 3680. Fax: (+41 22) 791 4836. e-mail: sign@who.int.
For further information, journalists may
contact Fadéla Chaïb at WHO Spokesperson's Office, Geneva,
Switzerland. Tel: (+4122) 791 3228. Fax: (+41 22) 791 4858. e-mail: chaibf@who.int.
All WHO Press Releases, Fact Sheets and Features as well as other
information on this subject can be obtained on Internet on the WHO
home page http://www.who.int |